Reactive oxygen species are critical mediators of coronary collateral development in a canine model

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 285, Issue 4 54-4, 2003, Pages

  Gu, Weidong ^a   Weihrauch, Dorothee ^a   Tanaka, Katsuya ^a   Tessmer, John P ^a   Pagel, Paul S ^a,b   Kersten, Judy R ^a   Chilian, William M ^c   Warltier, David C ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Collateral circulation; Free radicals; Growth substances

Indexed keywords

ACETYLCYSTEINE; ETHIDIUM; HYDROETHIDINE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY OBSTRUCTION; DOG; ENDOTHELIUM CELL; EXPERIMENTAL MODEL; FLUORESCENCE; HEART MUSCLE REPERFUSION; HUMAN; HUMAN CELL; INTERSTITIAL FLUID; MEDIATOR; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0141676778     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00318.2003     Document Type: Article

References (38)

1. Alberola A, Such L, Gil F, Zaragoza R, and Morcillo EJ. Protective effect of N-acetylcysteine on ischaemia-induced myocardial damage in canine heart. Naunyn Schmiedebergs Arch Pharmacol 343: 505-510, 1991.
2. Albini A, Morini M, D'Agostini F, Ferrari N, Campelli F, Arena G, Noonan DM, Pesce C, and De Flora S. Inhibition of angiogenesis-driven Kaposi's sarcoma tumor growth in nude mice by oral N-acetylcysteine. Cancer Res 61: 8171-8178, 2001.
3. Bao X, Lu C, and Frangos JA. Mechanism of temporal gradients in shear-induced ERK1/2 activation and proliferation in endothelial cells. Am J Physiol Heart Circ Physiol 281: H22-H29, 2001.
4. Chen W, Gabel S, Steenbergen C, and Murphy E. A redoxbased mechanism for cardioprotection induced by ischemic preconditioning in perfused rat heart. Circ Res 77: 424-429, 1995.
5. Colavitti R, Pani G, Bedogni B, Anzevino R, Borrello S, Waltenberger J, and Galeotti T. Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. J Biol Chem 277: 3101-3108, 2002.
6. Dawn B and Bolli R. Role of nitric oxide in myocardial preconditioning. Ann NY Acad Sci 962: 18-41, 2002.
7. Fujita M, Nakae I, Kihara Y, Hasegawa K, Nohara R, Ueda K, Tamaki S, Otsuka K, and Sasayama S. Determinants of collateral development in patients with acute myocardial infarction. Clin Cardiol 22: 595-599, 1999.
8. Greene EL, Velarde V, and Jaffa AA. Role of reactive oxygen species in bradykinin-induced mitogen-activated protein kinase and c-fos induction in vascular cells. Hypertension 35: 942-947, 2000.
9. Gross ER, LaDisa JF Jr, Weihrauch D, Olson LE, Kress TT, Hettrick DA, Pagel PS, Warltier DC, and Kersten JR. Reactive oxygen species modulate coronary wall shear stress and endothelial function during hyperglycemia. Am J Physiol Heart Circ Physiol 284: H1552-H1559, 2003.
10. Han YP, Tuan TL, Wu H, Hughes M, and Garner WL. TNF-α stimulates activation of pro-MMP2 in human skin through NF-κB mediated induction of MT1-MMP. J Cell Sci 114: 131-139, 2001.
11. Hartley CJ and Cole JS. An ultrasonic pulsed Doppler system for measuring blood flow in small vessels. J Appl Physiol 37: 626-629, 1974.
12. Henry TD, Archer SL, Nelson D, Weir EK, and From AH. Postischemic oxygen radical production varies with duration of ischemia. Am J Physiol Heart Circ Physiol 264: H1478-H1484, 1993.
13. Hirai T, Fujita M, Nakajima H, Asanoi H, Yamanishi K, Ohno A, and Sasayama S. Importance of collateral circulation for prevention of left ventricular aneurysm formation in acute myocardial infarction. Circulation 79: 791-796, 1989.
14. Huang RP, Peng A, Golard A, Hossain MZ, Huang R, Liu YG, and Boynton AL. Hydrogen peroxide promotes transformation of rat liver non-neoplastic epithelial cells through activation of epidermal growth factor receptor. Mol Carcinog 30: 209-217, 2001.
15. Jingjing L, Srinivasan B, Bian X, Downey HF, and Roque RS. Vascular endothelial growth factor is increased following coronary artery occlusion in the dog heart. Mol Cell Biochem 214: 23-30, 2000.
16. Kersten JR, McGough MF, Pagel PS, Tessmer JP, and Warltier DC. Temporal dependence of coronary collateral development. Cardiovasc Res 34: 306-312, 1997.
17. Kersten JR, Pagel PS, and Warltier DC. Protamine inhibits coronary collateral development in a canine model of repetitive coronary occlusion. Am J Physiol Heart Circ Physiol 268: H720-H728, 1995.
18. Koh TW, Carr-White GS, DeSouza AC, Ferdinand FD, Pepper JR, and Gibson DG. Effect of coronary occlusion on left ventricular function with and without collateral supply during beating heart coronary artery surgery. Heart 81: 285-291, 1999.
19. Lakshminarayanan V, Lewallen M, Frangogiannis NG, Evans AJ, Wedin KE, Michael LH, and Entman ML. Reactive oxygen intermediates induce monocyte chemotactic protein-1 in vascular endothelium after brief ischemia. Am J Pathol 159: 1301-1311, 2001.
20. Lelkes PI, Hahn KL, Sukovich DA, Karmiol S, and Schmidt DH. On the possible role of reactive oxygen species in angiogenesis. Adv Exp Med Biol 454: 295-310, 1998.
21. Matsunaga T, Warltier DC, Weihrauch DW, Moniz M, Tessmer J, and Chilian WM. Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide. Circulation 102: 3098-3103, 2000.
22. Matsunaga T, Weihrauch DW, Moniz MC, Tessmer J, Warltier DC, and Chilian WM. Angiostatin inhibits coronary angiogenesis during impaired production of nitric oxide. Circulation 105: 2185-2191, 2002.
23. Maulik N and Das DK. Redox signaling in vascular angiogenesis. Free Radic Biol Med 33: 1047-1060, 2002.
24. Miller FJ Jr, Gutterman DD, Rios CD, Heistad DD, and Davidson BL. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 82: 1298-1305, 1998.
25. Nakai S, Ishikawa K, Ogawa I, Koka H, Kamata N, Akiyama H, and Katori R. New collateral flow increasing early after coronary occlusion prevented myocardial necrosis in dogs. Heart Vessels 10: 171-177, 1995.
26. Okuyama H, Shimahara Y, Kawada N, Seki S, Kristensen DB, Yoshizato K, Uyama N, and Yamaoka Y. Regulation of cell growth by redox-mediated extracellular proteolysis of platelet-derived growth factor receptor beta. J Biol Chem 276: 28274-28280, 2001.
27. Olsson B, Johansson M, Gabrielsson J, and Bolme P. Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine. Eur J Clin Pharmacol 34: 77-82, 1988.
28. Perez-Castellano N, Garcia EJ, Abeytua M, Soriano J, Serrano JA, Elizaga J, Botas J, Lopez-Sendon JL, and Delcan JL. Influence of collateral circulation on in-hospital death from anterior acute myocardial infarction. J Am Coll Cardiol 31: 512-518, 1998.
29. Pocernich CB, La Fontaine M, and Butterfield DA. In-vivo glutathione elevation protects against hydroxyl free radical-induced protein oxidation in rat brain. Neurochem Int 36: 185-191, 2000.
30. Ruiz-Gines JA, Lopez-Ongil S, Gonzalez-Rubio M, Gonzalez-Santiago L, Rodriguez-Puyol M, and Rodriguez-Puyol D. Reactive oxygen species induce proliferation of bovine aortic endothelial cells. J Cardiovasc Pharmacol 35: 109-113, 2000.
31. Skyschally A, Schulz R, Gres P, Korth HG, and Heusch G. Attenuation of ischemic preconditioning in pigs by scavenging of free oxyradicals with ascorbic acid. Am J Physiol Heart Circ Physiol 284: H698-H703, 2003.
32. Tanaka K, Weihrauch D, Kehl F, Ludwig LM, LaDisa JF Jr, Kersten JR, Pagel PS, and Warltier DC. Mechanism of preconditioning by isoflurane in rabbits: a direct role for reactive oxygen species. Anesthesiology 97: 1485-1490, 2002.
33. Taylor BM, Fleming WE, Benjamin CW, Wu Y, Mathews WR, and Sun FF. The mechanism of cytoprotective action of lazaroids I: inhibition of reactive oxygen species formation and lethal cell injury during periods of energy depletion. J Pharmacol Exp Ther 276: 1224-1231, 1996.
34. Tessmer JP, Pagel PS, Weihrauch D, Ludwig LM, Chilian WM, Kersten JR, and Warltier DC. An intramyocardial catheter for repeated in vivo sampling of interstitial fluid. J Pharmacol Toxicol Methods 47: 73-78, 2002.
35. Thannickal VJ, Day RM, Klinz SG, Bastien MC, Larios JM, and Fanburg BL. Ras-dependent and -independent regulation of reactive oxygen species by mitogenic growth factors and TGF-β1. FASEB J 14: 1741-1748, 2000.
36. Wang Z, Castresana MR, and Newman WH. Reactive oxygen and NF-κB in VEGF-induced migration of human vascular smooth muscle cells. Biochem Biophys Res Commun 285: 669-674, 2001.
37. Weihrauch D, Tessmer J, Warltier DC, and Chilian WM. Repetitive coronary artery occlusions induce release of growth factors into the myocardial interstitium. Am J Physiol Heart Circ Physiol 275: H969-H976, 1998.
38. Yasuda M, Ohzeki Y, Shimizu S, Naito S, Ohtsuru A, Yamamoto T, and Kuroiwa Y. Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with ETS-1 in endothelial cells. Life Sci 64: 249-258, 1999.